From Liston Street Pulse:
Shares of MannKind Corporation (MNKD), a development-stage biopharmaceutical company, are up sharply in trading today after the resubmitted new drug application to U.S. FDA for AFREZZA for the treatment of adults with diabetes. MNDK shares struck an intra-day high of $5.64 earlier. At last check, the stock was trading 5.28% […]
The post MannKind Corporation Shares Up Sharply appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015